Table of Contents Chapter 1 Overview of Leuprorelin 1.1 Definition of Leuprorelin in This Report 1.2 Commercial Types of Leuprorelin 1.2.1 <95% 1.2.2 95%-98% 1.2.3 >98% 1.3 Downstream Application of Leuprorelin 1.3.1 Medical Uses 1.3.2 Veterinary Uses 1.3.3 Other 1.4 Development History of Leuprorelin 1.5 Market Status and Trend of Leuprorelin 2013-2023 1.5.1 Global Leuprorelin Market Status and Trend 2013-2023 1.5.2 Regional Leuprorelin Market Status and Trend 2013-2023 Chapter 2 Global Market Status and Forecast by Regions 2.1 Market Development of Leuprorelin 2013-2017 2.2 Production Market of Leuprorelin by Regions 2.2.1 Production Volume of Leuprorelin by Regions 2.2.2 Production Value of Leuprorelin by Regions 2.3 Demand Market of Leuprorelin by Regions 2.4 Production and Demand Status of Leuprorelin by Regions 2.4.1 Production and Demand Status of Leuprorelin by Regions 2013-2017 2.4.2 Import and Export Status of Leuprorelin by Regions 2013-2017 Chapter 3 Global Market Status and Forecast by Types 3.1 Production Volume of Leuprorelin by Types 3.2 Production Value of Leuprorelin by Types 3.3 Market Forecast of Leuprorelin by Types Chapter 4 Global Market Status and Forecast by Downstream Industry 4.1 Demand Volume of Leuprorelin by Downstream Industry 4.2 Market Forecast of Leuprorelin by Downstream Industry Chapter 5 Market Driving Factor Analysis of Leuprorelin 5.1 Global Economy Situation and Trend Overview 5.2 Leuprorelin Downstream Industry Situation and Trend Overview Chapter 6 Leuprorelin Market Competition Status by Major Manufacturers 6.1 Production Volume of Leuprorelin by Major Manufacturers 6.2 Production Value of Leuprorelin by Major Manufacturers 6.3 Basic Information of Leuprorelin by Major Manufacturers 6.3.1 Headquarters Location and Established Time of Leuprorelin Major Manufacturer 6.3.2 Employees and Revenue Level of Leuprorelin Major Manufacturer 6.4 Market Competition News and Trend 6.4.1 Merger, Consolidation or Acquisition News 6.4.2 Investment or Disinvestment News 6.4.3 New Product Development and Launch Chapter 7 Leuprorelin Major Manufacturers Introduction and Market Data 7.1 Takeda Company 7.1.1 Company profile 7.1.2 Representative Leuprorelin Product 7.1.3 Leuprorelin Sales, Revenue, Price and Gross Margin of Takeda Company 7.2 Beijing Boente Pharmaceutical 7.2.1 Company profile 7.2.2 Representative Leuprorelin Product 7.2.3 Leuprorelin Sales, Revenue, Price and Gross Margin of Beijing Boente Pharmaceutical 7.3 Shanghai Livzon Pharmaceutical 7.3.1 Company profile 7.3.2 Representative Leuprorelin Product 7.3.3 Leuprorelin Sales, Revenue, Price and Gross Margin of Shanghai Livzon Pharmaceutical 7.4 Selleck China 7.4.1 Company profile 7.4.2 Representative Leuprorelin Product 7.4.3 Leuprorelin Sales, Revenue, Price and Gross Margin of Selleck China 7.5 Hangzhou Peptide Biochemical 7.5.1 Company profile 7.5.2 Representative Leuprorelin Product 7.5.3 Leuprorelin Sales, Revenue, Price and Gross Margin of Hangzhou Peptide Biochemical 7.6 Chengdu Shenguo Biological Pharmaceutical 7.6.1 Company profile 7.6.2 Representative Leuprorelin Product 7.6.3 Leuprorelin Sales, Revenue, Price and Gross Margin of Chengdu Shenguo Biological Pharmaceutical 7.7 Wuhan East Kangyuan Technology 7.7.1 Company profile 7.7.2 Representative Leuprorelin Product 7.7.3 Leuprorelin Sales, Revenue, Price and Gross Margin of Wuhan East Kangyuan Technology 7.8 Wuhan Mingye Technology Development 7.8.1 Company profile 7.8.2 Representative Leuprorelin Product 7.8.3 Leuprorelin Sales, Revenue, Price and Gross Margin of Wuhan Mingye Technology Development 7.9 Nanjing Peptide Industry Biotechnology 7.9.1 Company profile 7.9.2 Representative Leuprorelin Product 7.9.3 Leuprorelin Sales, Revenue, Price and Gross Margin of Nanjing Peptide Industry Biotechnology 7.10 Wuhan East Kangyuan Technology 7.10.1 Company profile 7.10.2 Representative Leuprorelin Product 7.10.3 Leuprorelin Sales, Revenue, Price and Gross Margin of Wuhan East Kangyuan Technology 7.11 Tianjin Takeda Pharmaceutical 7.11.1 Company profile 7.11.2 Representative Leuprorelin Product 7.11.3 Leuprorelin Sales, Revenue, Price and Gross Margin of Tianjin Takeda Pharmaceutical 7.12 Wuhan East Kangyuan Technology 7.12.1 Company profile 7.12.2 Representative Leuprorelin Product 7.12.3 Leuprorelin Sales, Revenue, Price and Gross Margin of Wuhan East Kangyuan Technology Chapter 8 Upstream and Downstream Market Analysis of Leuprorelin 8.1 Industry Chain of Leuprorelin 8.2 Upstream Market and Representative Companies Analysis 8.3 Downstream Market and Representative Companies Analysis Chapter 9 Cost and Gross Margin Analysis of Leuprorelin 9.1 Cost Structure Analysis of Leuprorelin 9.2 Raw Materials Cost Analysis of Leuprorelin 9.3 Labor Cost Analysis of Leuprorelin 9.4 Manufacturing Expenses Analysis of Leuprorelin Chapter 10 Marketing Status Analysis of Leuprorelin 10.1 Marketing Channel 10.1.1 Direct Marketing 10.1.2 Indirect Marketing 10.1.3 Marketing Channel Development Trend 10.2 Market Positioning 10.2.1 Pricing Strategy 10.2.2 Brand Strategy 10.2.3 Target Client 10.3 Distributors/Traders List Chapter 11 Report Conclusion Chapter 12 Research Methodology and Reference 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Reference

List of Tables Table Advantage and Disadvantage of <95% Table Advantage and Disadvantage of 95%-98% Table Advantage and Disadvantage of >98% Table Production Volume of Leuprorelin by Regions 2013-2017 Table Production Value of Leuprorelin by Regions 2013-2017 Table Demand Volume of Leuprorelin by Regions 2013-2017 Table Production and Demand Status of Leuprorelin in Region One 2013-2017 Table Production and Demand Status of Leuprorelin in Region Two 2013-2017 Table Production and Demand Status of Leuprorelin in Region Three 2013-2017 Table Production and Demand Status of Leuprorelin in Region Four 2013-2017 Table Import Volume of Leuprorelin by Regions 2013-2017 Table Export Volume of Leuprorelin by Regions 2013-2017 Table Production Volume of Leuprorelin by Types 2013-2017 Table Production Value of Leuprorelin by Types 2013-2017 Table Production Volume Forecast of Leuprorelin by Types 2018-2023 Table Production Value Forecast of Leuprorelin by Types 2018-2023 Table Demand Volume of Leuprorelin by Downstream Industry 2013-2017 Table Demand Volume Forecast of Leuprorelin by Downstream Industry 2018-2023 Table Production Volume of Leuprorelin by Major Manufacturers 2013-2017 Table Production Value of Leuprorelin by Major Manufacturers 2013-2017 Table Headquarters Location and Established Time of Leuprorelin Major Manufacturer Table Employees and Revenue Level of Leuprorelin Major Manufacturer Table Representative Leuprorelin Product One of Takeda Company Table Representative Leuprorelin Product Two of Takeda Company Table Leuprorelin Sales, Revenue, Price and Gross Margin of Takeda Company 2013-2017 Table Representative Leuprorelin Product One of Beijing Boente Pharmaceutical Table Representative Leuprorelin Product Two of Beijing Boente Pharmaceutical Table Leuprorelin Sales, Revenue, Price and Gross Margin of Beijing Boente Pharmaceutical 2013-2017 Table Representative Leuprorelin Product One of Shanghai Livzon Pharmaceutical Table Representative Leuprorelin Product Two of Shanghai Livzon Pharmaceutical Table Leuprorelin Sales, Revenue, Price and Gross Margin of Shanghai Livzon Pharmaceutical 2013-2017 Table Representative Leuprorelin Product One of Selleck China Table Representative Leuprorelin Product Two of Selleck China Table Leuprorelin Sales, Revenue, Price and Gross Margin of Selleck China 2013-2017 Table Representative Leuprorelin Product One of Hangzhou Peptide Biochemical Table Representative Leuprorelin Product Two of Hangzhou Peptide Biochemical Table Leuprorelin Sales, Revenue, Price and Gross Margin of Hangzhou Peptide Biochemical 2013-2017 Table Representative Leuprorelin Product One of Chengdu Shenguo Biological Pharmaceutical Table Representative Leuprorelin Product Two of Chengdu Shenguo Biological Pharmaceutical Table Leuprorelin Sales, Revenue, Price and Gross Margin of Chengdu Shenguo Biological Pharmaceutical 2013-2017 Table Representative Leuprorelin Product One of Wuhan East Kangyuan Technology Table Representative Leuprorelin Product Two of Wuhan East Kangyuan Technology Table Leuprorelin Sales, Revenue, Price and Gross Margin of Wuhan East Kangyuan Technology 2013-2017 Table Representative Leuprorelin Product One of Wuhan Mingye Technology Development Table Representative Leuprorelin Product Two of Wuhan Mingye Technology Development Table Leuprorelin Sales, Revenue, Price and Gross Margin of Wuhan Mingye Technology Development 2013-2017 Table Representative Leuprorelin Product One of Nanjing Peptide Industry Biotechnology Table Representative Leuprorelin Product Two of Nanjing Peptide Industry Biotechnology Table Leuprorelin Sales, Revenue, Price and Gross Margin of Nanjing Peptide Industry Biotechnology 2013-2017 Table Representative Leuprorelin Product One of Wuhan East Kangyuan Technology Table Representative Leuprorelin Product Two of Wuhan East Kangyuan Technology Table Leuprorelin Sales, Revenue, Price and Gross Margin of Wuhan East Kangyuan Technology 2013-2017 Table Representative Leuprorelin Product One of Tianjin Takeda Pharmaceutical Table Representative Leuprorelin Product Two of Tianjin Takeda Pharmaceutical Table Leuprorelin Sales, Revenue, Price and Gross Margin of Tianjin Takeda Pharmaceutical 2013-2017 Table Representative Leuprorelin Product One of Wuhan East Kangyuan Technology Table Representative Leuprorelin Product Two of Wuhan East Kangyuan Technology Table Leuprorelin Sales, Revenue, Price and Gross Margin of Wuhan East Kangyuan Technology 2013-2017